1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019

  • March 2015
  • -
  • Infiniti Research Limited
  • -
  • 114 pages

Summary

Table of Contents

Search Inside

About Acquired Orphan Blood Diseases Therapeutics
Acquired orphan blood diseases are rare disorders and are characterized by the body's inability to produce a sufficient amount of RBCs. This is basically because of the improper functioning of bone marrow to produce RBCs in the blood. This leads to a decrease in platelet counts, which can eventually lead to anemia and thrombosis. The acquired orphan blood diseases are developed in the blood after the post fetal life; they are not caused because of genetic reasons. The major orphan blood diseases that contribute to acquired orphan blood diseases are the following: ITP, MDS, MF PNH, and PV.

TechNavio's analysts forecast the Global Acquired Orphan Blood Diseases Therapeutics market to grow at a CAGR of 12.29 percent over the period 2014-2019.


Covered in this Report
This report covers the present scenario and the growth prospects of the Global Acquired Orphan Blood Diseases Therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sale of marketed drugs used in the treatment of PNH, ITP, PV, MF, and MDS.

TechNavio's report, the Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Acquired Orphan Blood Diseases Therapeutics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.


Key Regions
• Americas
• APAC
• EMEA


Key Vendors
• Alexion Pharmaceuticals
• Amgen
• Celgene
• F. Hoffmann- La Roche
• GlaxoSmithKline
• Incyte

Other Prominent Vendors
• Cyclacel Pharmaceuticals
• CTI Biopharma (Cell Therapeutics)
• Eli Lilly
• Gilead Sciences
• Onconova Therapeutics
• MebVax Therapeutics
• Novartis
• Sanofi
• Shire Pharmaceuticals
• S* Bio Pte


Market Driver
• Exemption from Pricing Obstacle
• For a full, detailed list, view our report


Market Challenge
• Companies Hesitant to Invest in Rare Diseases Therapeutics
• For a full, detailed list, view our report


Market Trend
• Benefit from Untapped Market
• For a full, detailed list, view our report


Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hemophilia - Market Insights, Epidemiology and Market Forecast-2023

Hemophilia - Market Insights, Epidemiology and Market Forecast-2023

  • $ 7000
  • Industry report
  • April 2017
  • by Delve Insight

DelveInsight’s “Hemophilia- Market Insights, Epidemiology and Market Forecast-2023-7MM” Reports provides an overview of the disease and global market size of the Hemophilia for the United States, ...

Hemophilia Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

Hemophilia Treatment Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Hemophilia Treatment Drugs Market: Overview Hemophilia is a rare blood disorder. Hemophilia is a combination of two Greek words that is haima (blood) and philia (affection). Hemophilia is a hereditary ...

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

Apheresis Market by Product, Procedure, Application, Technology - Global Forecast to 2021

  • $ 5650
  • Industry report
  • February 2017
  • by MarketsandMarkets

The global apheresis market is projected to reach USD 2.06 billion by 2021, at a CAGR of 7.7% during the forecast period of 2016 to 2021. Growth in this market is majorly driven by the rising prevalence ...


Download Unlimited Documents from Trusted Public Sources

Blood Disease and HIV AIDS Statistics in Africa and Malawi

  • March 2017
    22 pages
  • Blood Disease  

    HIV AIDS  

    Infectious Dise...  

  • Africa  

    Malawi  

View report >

Blood Disease Statistics in the US - Forecast

  • March 2017
    10 pages
  • Blood Disease  

    Compression The...  

    Cardiovascular ...  

  • United States  

View report >

Blood Disease Statistics in the Netherlands

  • March 2017
    10 pages
  • Blood Disease  

    Intensive Care  

  • Netherlands  

View report >

Related Market Segments :

Blood Disease
Therapy
Pharmaceutical

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.